RN Collins: Federal Drug Policy, April 2026: The Operative Architecture of Cannabis Rescheduling, the Psychedelic Therapeutic Acceleration Directive, and the Road to June 29
Federal Drug Policy, April 2026: The Operative Architecture of Cannabis Rescheduling, the Psychedelic Therapeutic Acceleration Directive, and the Road to June 29 RN Collins | https://www.linkedin.com/in/rn-collins/ Abstract The week of April 18 through April 23, 2026...
Rod Kight Law Firm: New “Industrial Hemp” Definition – More Loopholes Instead of Real Reform?
The new federal 0.4mg Total THC limit that goes into effect this November has been the focus of much discussion in recent months but perhaps less discussed are the “industrial hemp” carveouts from that limit, and they may be broader than you think. Of course, for...
Rod Kight Law Firm: Schedule III for Medical Marijuana! Here’s the Big Shift, Broken Down
Here is our quick breakdown of rescheduling news: what the final order does, how DOJ says it can do it, a high-level overview of changes, and what comes next. What the Order Does Today, April 23, 2026, the United States Acting Attorney General, Todd Blanche, (the...
Zuber Lawler: What Schedule III Means for State-Licensed Medical Cannabis Companies
What Schedule III Means for State-Licensed Medical Cannabis Companies Article by: Ivy Perez-Bader, Raza Lawrence, and Tom Zuber On April 23, 2026, the Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) took a historic step the cannabis industry...
KMK Law: From Schedule I to III: A Partial Tax Reset for Cannabis Businesses
By Tanner C. Fisher on 4.28.2026 Key Takeaways The rescheduling of certain cannabis products to Schedule III represents a meaningful shift in federal cannabis policy and offers long-awaited tax relief for portions of the industry. However, the benefits are limited in...Top 200 Cannabis Lawyers
We Support